Learn more

SHENZHEN TARGETRX INC

Overview
  • Total Patents
    228
  • GoodIP Patent Rank
    6,379
  • Filing trend
    0.0%
About

SHENZHEN TARGETRX INC has a total of 228 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2016. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are SUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD, SUZHOU ZELGEN BIOPHARMACEUTICAL CO LTD and TP THERAPEUTICS INC.

Patent filings in countries

World map showing SHENZHEN TARGETRX INCs patent filings in countries
# Country Total Patents
#1 China 90
#2 WIPO (World Intellectual Property Organization) 82
#3 EPO (European Patent Office) 29
#4 United States 24
#5 Japan 3

Patent filings per year

Chart showing SHENZHEN TARGETRX INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wang Yihan 228
#2 Li Huanyin 82
#3 Zhao Jiuyang 62
#4 Ren Xingye 40
#5 Liu Zhiqiang 25
#6 Xing Qingfeng 25
#7 Ai Yixin 24
#8 Jin Jian 14
#9 Li Yuanyin 2
#10 Al Yixin 1

Latest patents

Publication Filing date Title
WO2021057877A1 Substituted aromatic fused ring derivative and composition comprising same, and use thereof
WO2021057796A1 Substituted fused tricyclic derivative, and composition and use thereof
CN111620821A Substituted pyrazole compounds, compositions containing the same and uses thereof
CN111574521A Substituted aromatic fused ring derivatives, compositions and uses thereof
WO2020114388A1 Substituted pyrazolo[1,5-a]pyridine compound, composition containing the same and use thereof
CN111349084A Aminopyrimidines useful for inhibiting protein kinase activity
WO2020108522A1 Preparation method for deuterated macrocyclic compound
CN110577543A dihydroimidazopyrazinone compound, composition containing dihydroimidazopyrazinone compound and application of dihydroimidazopyrazinone compound
CN110317211A A kind of substituted polycyclic pyridinone compounds and its prodrug
EP3808746A1 Alkynyl (hetero) aromatic ring compounds used for inhibiting protein kinase activity
CN110256408A A kind of diaryl pyrazole azole compounds and the composition comprising the compound and application thereof
WO2020007234A1 Alkynyl(hetero)aromatic compound for inhibiting protein kinase activity
CN110066272A Substituted benzo [d] glyoxaline compound and its pharmaceutical composition
WO2019223671A1 Substituted aminoquinazoline compound, and pharmaceutical composition and use thereof
WO2019201194A1 Substituted pyrrolotriazine compound, pharmaceutical composition thereof and use thereof
WO2019201131A1 Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activity
US2021094939A1 Substituted diamino heterocyclic carboxamide compound and a composition containing the compound and use thereof
WO2019179494A1 Substituted pentadecanedioic acid compound and pharmaceutical composition and use thereof
CN109651359A Substituted nicotinamide compound and medical composition and its use
CN109851638A Substituted diaminopyrimidine compounds